Two Sigma Securities’s Grace Therapeutics, Inc. Common Stock GRCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,515
| Closed | -$7.92K | – | 2097 |
|
|
2023
Q2 | $7.92K | Buy |
+2,515
| New | +$7.92K | ﹤0.01% | 1109 |
|
|
2022
Q4 | – | Sell |
-2,823
| Closed | -$10K | – | 2095 |
|
|
2022
Q3 | $10K | Sell |
2,823
-1,426
| -34% | -$5.05K | ﹤0.01% | 1191 |
|
|
2022
Q2 | $22K | Buy |
+4,249
| New | +$22K | ﹤0.01% | 988 |
|
|
2022
Q1 | – | Sell |
-2,453
| Closed | -$19K | – | 1645 |
|
|
2021
Q4 | $19K | Buy |
2,453
+225
| +10% | +$1.74K | ﹤0.01% | 919 |
|
|
2021
Q3 | $27K | Buy |
+2,228
| New | +$27K | ﹤0.01% | 763 |
|
|
2021
Q2 | – | Sell |
-1,007
| Closed | -$29K | – | 1127 |
|
|
2021
Q1 | $29K | Buy |
+1,007
| New | +$29K | ﹤0.01% | 533 |
|
|
2020
Q4 | – | Sell |
-326
| Closed | -$3K | – | 1188 |
|
|
2020
Q3 | $3K | Buy |
+326
| New | +$3K | ﹤0.01% | 482 |
|